about
2-Aminoadipic acid is a biomarker for diabetes riskAmino Acid Signatures to Evaluate the Beneficial Effects of Weight Loss.Longitudinal and postural changes of blood pressure predict dementia: the Malmö Preventive Project.Mild renal dysfunction and metabolites tied to low HDL cholesterol are associated with monocytosis and atherosclerosis.A genetic variant of the atrial natriuretic peptide gene is associated with left ventricular hypertrophy in a non-diabetic population--the Malmö preventive project studyNovel and conventional biomarkers for prediction of incident cardiovascular events in the community.Atrial natriuretic peptide and type 2 diabetes development--biomarker and genotype association study.Distinct metabolomic signatures are associated with longevity in humans.Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies.Low plasma level of atrial natriuretic peptide predicts development of diabetes: the prospective Malmo Diet and Cancer study.Dimethylglycine Deficiency and the Development of Diabetes.Cystatin C and Risk of Diabetes and the Metabolic Syndrome - Biomarker and Genotype Association Analyses.Metabolite profiling identifies pathways associated with metabolic risk in humansPostprandial Levels of Branch Chained and Aromatic Amino Acids Associate with Fasting GlycaemiaA diabetes-predictive amino acid score and future cardiovascular disease.Defensive coping and essential amino acid markers as possible predictors for structural vascular disease in an African and Caucasian male cohort: The SABPA study.Response to letter to the editor 'Serum cystatin-C levels correlate with endothelial dysfunction in patients with the metabolic syndrome'.Plasma metabolite profiles, cellular cholesterol efflux, and non-traditional cardiovascular risk in patients with CKD.Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.Monitoring of cerebral oximetry during head-up tilt test in adults with history of syncope and orthostatic intolerance.Biomarkers of microvascular endothelial dysfunction predict incident dementia: a population-based prospective study.Glycaemic and nonglycaemic effects of pioglitazone in triple oral therapy of patients with type 2 diabetes.The shrunken pore syndrome is associated with declined right ventricular systolic function in a heart failure population - the HARVEST study.Natriuretic peptides as indicators of cardiac remodeling in hypertensive patients.Autonomic dysfunction is associated with cardiac remodelling in heart failure patients.N-Terminal Prosomatostatin and Risk of Vascular Dementia.Atrial Natriuretic Peptide in the High Normal Range Is Associated With Lower Prevalence of Insulin Resistance.Cardiovascular risk after hospitalisation for unexplained syncope and orthostatic hypotension.Erratum: Distinct metabolomic signatures are associated with longevity in humansCharacteristics and prognosis of healthy severe obesity (HSO) subjects - The Malmo Preventive ProjectA clinically confirmed family history for early myocardial infarction is associated with increased risk of obesity, insulin resistance and metabolic syndromeHigh levels of cystatin C predict the metabolic syndrome: the prospective Malmö Diet and Cancer StudyOrthostatic Hypotension and Cardiac Changes After Long-Term Follow-UpObesity and metabolic features associated with long-term developing diastolic dysfunction in an initially healthy population-based cohortMetabolomic signatures in atherosclerotic disease: what is the potential use?Exploration of pathophysiological pathways for incident atrial fibrillation using a multiplex proteomic chipProspective associations between cardiac stress, glucose dysregulation and executive cognitive function in Black men: The Sympathetic activity and Ambulatory Blood Pressure in Africans studyCardiovascular biomarkers predict post-discharge re-hospitalization risk and mortality among Swedish heart failure patientsPopulation-Level Analysis to Determine Parameters That Drive Variation in the Plasma Metabolite Profiles
P50
Q24617890-2E012DF6-215D-4A65-A44B-5929768C45C8Q33623813-C9634245-9140-4917-AAC1-9E95C19675E3Q33705284-4F3DA7CD-6275-4C1D-8D9D-00AF806625BCQ33819382-5627529E-590F-4220-9DE7-38A5C3D2188DQ34782910-BC9EBBE8-3BC6-4B22-87F8-21C4A2B49514Q34960396-63578C1E-6E7A-409C-8ED5-1474F04A1345Q35106848-DCC6F903-DAD5-47B1-8E03-85D8F72D5CBAQ35411463-435A9848-2D5B-4B66-9E06-B8AC9B7827E4Q35432757-2B0B43AB-0AA1-42FA-9080-D015C086A446Q35744489-AFD13C47-02EC-4BC2-8503-8906FBC8CF3CQ35881734-790724E8-C52C-4259-B360-1D9F17E8DAE4Q36027716-5E08E11B-D402-46C7-B8AF-AF20F262A854Q36037142-A14174C0-76F0-4ED6-9F9C-377FB25E4E05Q36914277-705BDD80-854B-4391-8815-DCC96D0587F5Q36988260-2FFC0620-223E-4056-8707-02E15EB5385CQ40327183-08FAAC7E-34A8-4972-B0D4-F28A54960143Q45215002-FE301E4F-6EF2-45B1-8131-31C9EDB55890Q47378700-A05D7322-E55F-4BE2-8A9D-C75CBDE60C07Q47720932-DE0BD5FA-380F-4A68-939A-11A1AB9A9F96Q47784985-A5AB512B-6A03-434D-AF4C-00069EFCC0AEQ48277492-53DCF0F9-15A9-4375-BEB1-6D2EF2B2AA89Q48457425-2081E97A-79CF-4999-971B-3F0E3462D1A0Q48516102-5A3A4BA4-C8D7-4576-94F0-7F31EF45534AQ48548331-91CFC9A5-C5F7-4DE0-B960-546E73100E62Q49336091-41B5A6F1-12C6-44A6-AB8E-60D41C57F4EFQ50273018-1C345E69-3CA4-4560-A9FB-8ADFB8EE96F2Q53799923-E401C859-626F-4539-BA10-287F6AA1C9A4Q55033627-3B963477-2E28-4A12-B6E5-54FED66274B9Q57308206-B28C4772-B553-4DA2-A05A-28592EC5A429Q61634508-985F9F0B-E6D4-4F9C-AC2E-47AF85CA8773Q83462942-01C8366B-7687-4544-A510-2612CAE0C0E1Q86131655-39105D62-3863-441D-9D4A-C3B6BD7A97A0Q86866909-C8EF6A0D-339A-4E74-82FE-5857D9F0431FQ88431619-7D6AB950-4F0F-4BF2-988F-D4BB94E181B3Q89416115-FB4FD5F7-A88F-44DF-AD8A-F602E207A3F3Q90577525-FD7C27E2-1293-4126-A1DE-CD6B51A208E1Q90582297-7F0287AB-CF2C-4412-9EC9-E7DE90D417F4Q92145850-B8AE7C4A-5942-4A62-8C10-B1DB671FBED5Q93178699-27986DA7-6BB4-4C8C-BC15-5EA12EF888DB
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Martin Magnusson
@ast
Martin Magnusson
@en
Martin Magnusson
@es
Martin Magnusson
@nl
type
label
Martin Magnusson
@ast
Martin Magnusson
@en
Martin Magnusson
@es
Martin Magnusson
@nl
prefLabel
Martin Magnusson
@ast
Martin Magnusson
@en
Martin Magnusson
@es
Martin Magnusson
@nl
P106
P1153
56785324000
P31
P496
0000-0003-1710-5936